All Updates

New findings led by researchers at the American Cancer Society and American Cancer Society Cancer Action Network (ACS CAN) show that regional trial eligibility screening holds the promise of substantially increasing the number of patients who are found eligible to enroll in cancer clinical trials.

The nation’s drug shortage crisis continues to affect cancer patients and survivors with 1 in every 10 (10%) reporting impacts to care, a majority of whom have had difficulties finding substitute medications (68%) and cited treatment delays (45%). The data is part of a new survey by the American Cancer Society Cancer Action Network (ACS CAN).

The Award is the Highest Honor Presented by the American Cancer Society Cancer Action Network

WASHINGTON, D.C. – October 12, 2023 –Today, the American Cancer Society and the American Cancer Society Cancer Action Network (ACS CAN) joined with other leading national patient groups in filing an amicus curiae (or friend-of-the-court) brief urging the Supreme Court to take up the case of

WASHINGTON, D.C.— October 12, 2023 — Next Wednesday, the Senate Health Education Labor and Pensions Committee has scheduled a hearing on the confirmation of Dr. Monica Bertagnolli as the next director of the National Institutes of Health (NIH). The American Cancer Society Cancer Action Network sent a letter to

HARRISBURG, PA – OCTOBER 12, 2023 – Today, Rep. Kyle Mullins introduced House Bill 1754 to increase Pennsylvanians’ access to biomarker testing, following Sen. Devlin Robinson’s introduction of a companion bill, Senate Bill 954, in the Senate last week. A game-changing part of cancer care, biomarker testing opens the door

Today, the American Cancer Society Cancer Action Network (ACS CAN) was overjoyed to see the legislature pass oral chemotherapy fairness legislation. ACS CAN looks forward to seeing the Governor sign this critical legislation into law soon and celebrating our volunteers’ hard work to get this legislation over the finish line.